XML 38 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
 
 
Cash, Cash Equivalents and Restricted Cash
 
 
June 30,
2019
 
June 30,
2018
 
September 30, 2018
 
September 30, 2017
Cash and cash equivalents
 
$
533.7

 
$
506.7

 
$
452.6

 
$
558.4

Restricted cash
 
42.3

 
7.7

 
9.6

 
10.3

Cash, cash equivalents and restricted cash
 
$
576.0

 
$
514.4

 
$
462.2

 
$
568.7


Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
 
 
Cash, Cash Equivalents and Restricted Cash
 
 
June 30,
2019
 
June 30,
2018
 
September 30, 2018
 
September 30, 2017
Cash and cash equivalents
 
$
533.7

 
$
506.7

 
$
452.6

 
$
558.4

Restricted cash
 
42.3

 
7.7

 
9.6

 
10.3

Cash, cash equivalents and restricted cash
 
$
576.0

 
$
514.4

 
$
462.2

 
$
568.7


Shares Used in Computing Basic and Diluted Earnings Per Share
Shares used in computing basic and diluted earnings per share are as follows: 
 
 
Three Months Ended
June 30,
 
Nine Months Ended
June 30,
 
 
2019
 
2018
 
2019
 
2018
Denominator (thousands of shares):
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding — basic
 
174,759

 
173,991

 
174,541

 
173,744

Incremental shares issuable for stock options and awards (a)
 

 
2,816

 
2,848

 
2,958

Weighted-average common shares outstanding — diluted
 
174,759

 
176,807

 
177,389

 
176,702


(a)
For the three months ended June 30, 2019, incremental shares of 2,576 have been excluded as such incremental shares would be antidilutive due to the net loss for the period. For the nine months ended June 30, 2019, there were 244 shares associated with outstanding stock option awards that were excluded from the computation of diluted earnings per share above because their effect was antidilutive. There were no such shares for the three and nine months ended June 30, 2018.